epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Ultravist

iopromide

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Black Box Warnings .

Not for Intrathecal Use

inadvertent intrathecal administration may cause death, convulsions, cerebral hemorrhages, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema; not approved for intrathecal use

Adult Dosing .

Dosage forms:  INJ: 300 mg per mL, 370 mg per mL

Special Note

[strength clarification]
Info: strength expressed as iodine concentration

angiocardiography

[coronary artery]
Dose: 3-14 mL (370 mg per mL) intra-arterially x1; Max: 225 mL/total dose
[left ventricle]
Dose: 30-60 mL (370 mg per mL) intra-arterially x1; Max: 225 mL/total dose

aortography

[individualize dose (370 mg per mL) intra-arterially x1]
Max: 225 mL/total dose

cerebral arteriography

[carotid arteries]
Dose: 3-12 mL (300 mg per mL) intra-arterially x1; Max: 150 mL/total dose
[vertebral arteries]
Dose: 4-12 mL (300 mg per mL) intra-arterially x1; Max: 150 mL/total dose
[aortic arch]
Dose: 20-50 mL (300 mg per mL) intra-arterially x1; Max: 150 mL/total dose

peripheral arteriography

[subclavian or femoral artery]
Dose: 5-40 mL (300 mg per mL) intra-arterially x1; Max: 250 mL/total dose
[aortic bifurcation]
Dose: 25-50 mL (300 mg per mL) intra-arterially x1; Max: 250 mL/total dose

visceral angiography

[individualize dose (370 mg per mL) intra-arterially x1]
Max: 225 mL/total dose

computed tomography, head or body

[50-200 mL (300 mg per mL) IV x1]
Max: 200 mL/total dose; Alt: 41-162 mL (370 mg per mL) IV x1, max 162 mL/total dose

excretory urography

[1 mL/kg/dose (300 mg per mL) IV x1]
Max: 100 mL/total dose

mammography adjunct

[1.5 mL/kg/dose (300 mg per mL or 370 mg per mL) IV x1]
Max: 150 mL/total dose

renal dosing

[see below]
renal impairment: not defined, caution advised
HD/PD: not defined, caution advised

hepatic dosing

[see below]
hepatic impairment: not defined, caution advised in hepatorenal disease

Peds Dosing .

Dosage forms:  INJ: 300 mg per mL, 370 mg per mL

Special Note

[strength clarification]
Info: strength expressed as iodine concentration

radiography, cardiac chambers and related arteries

[>2 yo]
Dose: 1-2 mL/kg/dose (370 mg per mL) intra-arterially x1; Max: 4 mL/kg/total dose

computed tomography, head or body

[>2 yo]
Dose: 1-2 mL/kg/dose (300 mg per mL) IV x1; Max: 3 mL/kg/total dose up to 200 mL

excretory urography

[>2 yo]
Dose: 1-2 mL/kg/dose (300 mg per mL) IV x1; Max: 3 mL/kg/total dose up to 100 mL

renal dosing

[see below]
renal impairment: not defined, caution advised
HD/PD: not defined, caution advised

hepatic dosing

[see below]
hepatic impairment: not defined, caution advised

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@62a13d0b
  • intrathecal use
  • symptomatic hyperthyroidism
  • homocystinuria (angiocardiography use)
  • hypersensitivity to drug or ingredient
  • caution: hypersensitivity to other iodinated contrast media
  • caution: patients <3 yo
  • caution: asthma
  • caution: allergies, known
  • caution: renal impairment
  • caution: renal impairment risk
  • caution: arterial disease, severe
  • caution: venous disease, severe
  • caution: hyperthyroidism
  • caution: autonomously functioning thyroid nodule
  • caution: cardiovascular disease
  • caution: CHF
  • caution: hepatorenal disease
  • caution: cardiorenal disease
  • caution: congenital cardiac conditions (peds patients)
  • caution: thromboembolism risk (angiography use)
  • caution: pheochromocytoma
  • caution: myasthenia gravis

Drug Interactions .

Overview

iopromide

contrast agent

Interaction Characteristics:
  • nephrotoxicity
  • thrombogenic effects
Other Info
  • avoid combo with radioactive iodine; iopromide may decrease thyroid uptake of radioactive iodine, efficacy for at least 6wk

Contraindicated

  • cidofovir
  • Ultravist (iopromide)
    +
    cidofovir
    1 interaction

    Contraindicated

    iopromide + cidofovir

    contraindicated; D/C iopromide at least 7 days prior to cidofovir tx: combo may incr. cidofovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

Avoid/Use Alternative

  • aldesleukin
  • Ultravist (iopromide)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    iopromide + aldesleukin

    use alternative or monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • amikacin
  • Ultravist (iopromide)
    +
    amikacin
    1 interaction

    Avoid/Use Alternative

    iopromide + amikacin

    use alternative or monitor amikacin levels, renal function, ototoxicity: combo may incr. amikacin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • amikacin inhaled
  • Ultravist (iopromide)
    +
    amikacin inhaled
    1 interaction

    Avoid/Use Alternative

    iopromide + amikacin inhaled

    use alternative or monitor renal function, ototoxicity: combo may incr. amikacin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • amiloride
  • Ultravist (iopromide)
    +
    amiloride
    1 interaction

    Avoid/Use Alternative

    iopromide + amiloride

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • bumetanide
  • Ultravist (iopromide)
    +
    bumetanide
    1 interaction

    Avoid/Use Alternative

    iopromide + bumetanide

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • chlorothiazide
  • Ultravist (iopromide)
    +
    chlorothiazide
    1 interaction

    Avoid/Use Alternative

    iopromide + chlorothiazide

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • chlorthalidone
  • Ultravist (iopromide)
    +
    chlorthalidone
    1 interaction

    Avoid/Use Alternative

    iopromide + chlorthalidone

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • clofarabine
  • Ultravist (iopromide)
    +
    clofarabine
    1 interaction

    Avoid/Use Alternative

    iopromide + clofarabine

    avoid clofarabine during 5 day clofarabine tx; monitor CBC, renal function, BP: combo may incr. clofarabine levels, risk of serious infection, myelosuppression, nephrotoxicity, hypotension, other adverse effects (additive effects)

  • ethacrynic acid
  • Ultravist (iopromide)
    +
    ethacrynic acid
    1 interaction

    Avoid/Use Alternative

    iopromide + ethacrynic acid

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • foscarnet
  • Ultravist (iopromide)
    +
    foscarnet
    1 interaction

    Avoid/Use Alternative

    iopromide + foscarnet

    use alternative or monitor CBC, renal function: combo may incr. foscarnet levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • furosemide
  • Ultravist (iopromide)
    +
    furosemide
    1 interaction

    Avoid/Use Alternative

    iopromide + furosemide

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • ganciclovir
  • Ultravist (iopromide)
    +
    ganciclovir
    1 interaction

    Avoid/Use Alternative

    iopromide + ganciclovir

    use alternative or monitor CBC, renal function: combo may incr. ganciclovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • gentamicin
  • Ultravist (iopromide)
    +
    gentamicin
    1 interaction

    Avoid/Use Alternative

    iopromide + gentamicin

    use alternative or monitor gentamicin levels, renal function, ototoxicity: combo may incr. gentamicin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • hydrochlorothiazide
  • Ultravist (iopromide)
    +
    hydrochlorothiazide
    1 interaction

    Avoid/Use Alternative

    iopromide + hydrochlorothiazide

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • indapamide
  • Ultravist (iopromide)
    +
    indapamide
    1 interaction

    Avoid/Use Alternative

    iopromide + indapamide

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • iodixanol
  • Ultravist (iopromide)
    +
    iodixanol
    1 interaction

    Avoid/Use Alternative

    iopromide + iodixanol

    use alternative or monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism, other adverse effects (additive effects, duplicate therapy)

  • iohexol
  • Ultravist (iopromide)
    +
    iohexol
    1 interaction

    Avoid/Use Alternative

    iopromide + iohexol

    use alternative or monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism, other adverse effects (additive effects, duplicate therapy)

  • iomeprol
  • Ultravist (iopromide)
    +
    iomeprol
    1 interaction

    Avoid/Use Alternative

    iopromide + iomeprol

    use alternative or monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism, other adverse effects (additive effects, duplicate therapy)

  • iopamidol
  • Ultravist (iopromide)
    +
    iopamidol
    1 interaction

    Avoid/Use Alternative

    iopromide + iopamidol

    use alternative or monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism, other adverse effects (additive effects, duplicate therapy)

  • iopromide
  • Ultravist (iopromide)
    +
    iopromide
    1 interaction

    Avoid/Use Alternative

    iopromide + iopromide

    use alternative or monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects, duplicate therapy)

  • iothalamate meglumine
  • Ultravist (iopromide)
    +
    iothalamate meglumine
    1 interaction

    Avoid/Use Alternative

    iopromide + iothalamate meglumine

    use alternative or monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism, other adverse effects (additive effects, duplicate therapy)

  • ioversol
  • Ultravist (iopromide)
    +
    ioversol
    1 interaction

    Avoid/Use Alternative

    iopromide + ioversol

    use alternative or monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism, other adverse effects (additive effects, duplicate therapy)

  • magnesium citrate
  • Ultravist (iopromide)
    +
    magnesium citrate
    1 interaction

    Avoid/Use Alternative

    iopromide + magnesium citrate

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • mannitol
  • Ultravist (iopromide)
    +
    mannitol
    1 interaction

    Avoid/Use Alternative

    iopromide + mannitol

    avoid combo: combo may incr. mannitol levels, risk of nephrotoxicity, neurotoxicity (including life-threatening), other adverse effects (additive effects)

  • methotrexate
  • Ultravist (iopromide)
    +
    methotrexate
    1 interaction

    Avoid/Use Alternative

    iopromide + methotrexate

    use alternative or monitor CBC, renal function: combo may incr. methotrexate levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • metolazone
  • Ultravist (iopromide)
    +
    metolazone
    1 interaction

    Avoid/Use Alternative

    iopromide + metolazone

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • oxaliplatin
  • Ultravist (iopromide)
    +
    oxaliplatin
    1 interaction

    Avoid/Use Alternative

    iopromide + oxaliplatin

    use alternative or monitor ECG, CBC, renal function, ototoxicity: combo may incr. oxaliplatin levels, risk of QT prolongation, cardiac arrhythmias, serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • pentamidine
  • Ultravist (iopromide)
    +
    pentamidine
    1 interaction

    Avoid/Use Alternative

    iopromide + pentamidine

    use alternative or monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • polyethylene glycol
  • Ultravist (iopromide)
    +
    polyethylene glycol
    1 interaction

    Avoid/Use Alternative

    iopromide + polyethylene glycol

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • polyethylene glycol/electrolytes
  • Ultravist (iopromide)
    +
    polyethylene glycol/ electrolytes
    1 interaction

    Avoid/Use Alternative

    iopromide + polyethylene glycol/ electrolytes

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • polymyxin B
  • Ultravist (iopromide)
    +
    polymyxin B
    1 interaction

    Avoid/Use Alternative

    iopromide + polymyxin B

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • sodium picosulfate
  • Ultravist (iopromide)
    +
    sodium picosulfate
    1 interaction

    Avoid/Use Alternative

    iopromide + sodium picosulfate

    avoid combo: combo may incr. risk of nephrotoxicity (possible additive effects)

  • spironolactone
  • Ultravist (iopromide)
    +
    spironolactone
    1 interaction

    Avoid/Use Alternative

    iopromide + spironolactone

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • streptomycin
  • Ultravist (iopromide)
    +
    streptomycin
    1 interaction

    Avoid/Use Alternative

    iopromide + streptomycin

    use alternative or monitor renal function, ototoxicity: combo may incr. streptomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • streptozocin
  • Ultravist (iopromide)
    +
    streptozocin
    1 interaction

    Avoid/Use Alternative

    iopromide + streptozocin

    use alternative or monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • sulfate bowel prep
  • Ultravist (iopromide)
    +
    sulfate bowel prep
    1 interaction

    Avoid/Use Alternative

    iopromide + sulfate bowel prep

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • tenofovir disoproxil
  • Ultravist (iopromide)
    +
    tenofovir disoproxil
    1 interaction

    Avoid/Use Alternative

    iopromide + tenofovir disoproxil

    use alternative or monitor renal function: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • tobramycin
  • Ultravist (iopromide)
    +
    tobramycin
    1 interaction

    Avoid/Use Alternative

    iopromide + tobramycin

    use alternative or monitor tobramycin levels, renal function, ototoxicity: combo may incr. tobramycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • tobramycin inhaled
  • Ultravist (iopromide)
    +
    tobramycin inhaled
    1 interaction

    Avoid/Use Alternative

    iopromide + tobramycin inhaled

    use alternative or monitor renal function, ototoxicity: combo may incr. tobramycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • torsemide
  • Ultravist (iopromide)
    +
    torsemide
    1 interaction

    Avoid/Use Alternative

    iopromide + torsemide

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • tranexamic acid
  • Ultravist (iopromide)
    +
    tranexamic acid
    1 interaction

    Avoid/Use Alternative

    iopromide + tranexamic acid

    avoid combo: combo may incr. risk of thromboembolism (additive effects)

  • triamterene
  • Ultravist (iopromide)
    +
    triamterene
    1 interaction

    Avoid/Use Alternative

    iopromide + triamterene

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • vaccinia immune globulin
  • Ultravist (iopromide)
    +
    vaccinia immune globulin
    1 interaction

    Avoid/Use Alternative

    iopromide + vaccinia immune globulin

    use alternative or monitor renal function, thrombosis signs/symptoms; use lowest vaccinia immune globulin concentration and infusion rate possible: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • valganciclovir
  • Ultravist (iopromide)
    +
    valganciclovir
    1 interaction

    Avoid/Use Alternative

    iopromide + valganciclovir

    use alternative or monitor CBC, renal function: combo may incr. ganciclovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

Monitor/Modify Tx

  • abemaciclib
  • Ultravist (iopromide)
    +
    abemaciclib
    1 interaction

    Monitor/Modify Tx

    iopromide + abemaciclib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • abrocitinib
  • Ultravist (iopromide)
    +
    abrocitinib
    1 interaction

    Monitor/Modify Tx

    iopromide + abrocitinib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • acyclovir
  • Ultravist (iopromide)
    +
    acyclovir
    1 interaction

    Monitor/Modify Tx

    iopromide + acyclovir

    monitor renal function: combo may incr. acyclovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • adefovir dipivoxil
  • Ultravist (iopromide)
    +
    adefovir dipivoxil
    1 interaction

    Monitor/Modify Tx

    iopromide + adefovir dipivoxil

    monitor renal function: combo may incr. adefovir levels, risk of nephrotoxicity, other adverse effect (renal excretion decreased by nephrotoxic agents, additive effects)

  • aflibercept
  • Ultravist (iopromide)
    +
    aflibercept
    1 interaction

    Monitor/Modify Tx

    iopromide + aflibercept

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • alectinib
  • Ultravist (iopromide)
    +
    alectinib
    1 interaction

    Monitor/Modify Tx

    iopromide + alectinib

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • aliskiren
  • Ultravist (iopromide)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    iopromide + aliskiren

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • allopurinol
  • Ultravist (iopromide)
    +
    allopurinol
    1 interaction

    Monitor/Modify Tx

    iopromide + allopurinol

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • aminocaproic acid
  • Ultravist (iopromide)
    +
    aminocaproic acid
    1 interaction

    Monitor/Modify Tx

    iopromide + aminocaproic acid

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • amphotericin
  • Ultravist (iopromide)
    +
    amphotericin
    1 interaction

    Monitor/Modify Tx

    iopromide + amphotericin

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • angiotensin II
  • Ultravist (iopromide)
    +
    angiotensin II
    1 interaction

    Monitor/Modify Tx

    iopromide + angiotensin II

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • anthrax immune globulin
  • Ultravist (iopromide)
    +
    anthrax immune globulin
    1 interaction

    Monitor/Modify Tx

    iopromide + anthrax immune globulin

    monitor renal function, thrombosis signs/symptoms; use lowest anthrax immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • anti-inhibitor coagulant complex
  • Ultravist (iopromide)
    +
    anti-inhibitor coagulant complex
    1 interaction

    Monitor/Modify Tx

    iopromide + anti-inhibitor coagulant complex

    monitor thrombosis signs/symptoms, especially with anti-inhibitor coagulant complex dose >100 units/kg: combo may incr. risk of thromboembolism (additive effects)

  • antihemophilic factor (factor VIII)/von Willebrand factor complex
  • Ultravist (iopromide)
    +
    antihemophilic factor (factor VIII)/ von Willebrand factor complex
    1 interaction

    Monitor/Modify Tx

    iopromide + antihemophilic factor (factor VIII)/ von Willebrand factor complex

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • asciminib
  • Ultravist (iopromide)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    iopromide + asciminib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • asparaginase
  • Ultravist (iopromide)
    +
    asparaginase
    1 interaction

    Monitor/Modify Tx

    iopromide + asparaginase

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • aspirin
  • Ultravist (iopromide)
    +
    aspirin
    1 interaction

    Monitor/Modify Tx

    iopromide + aspirin

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • atidarsagene autotemcel
  • Ultravist (iopromide)
    +
    atidarsagene autotemcel
    1 interaction

    Monitor/Modify Tx

    iopromide + atidarsagene autotemcel

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • auranofin
  • Ultravist (iopromide)
    +
    auranofin
    1 interaction

    Monitor/Modify Tx

    iopromide + auranofin

    monitor renal function: combo may incr. auranofin levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • avatrombopag
  • Ultravist (iopromide)
    +
    avatrombopag
    1 interaction

    Monitor/Modify Tx

    iopromide + avatrombopag

    monitor platelets, thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • axitinib
  • Ultravist (iopromide)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    iopromide + axitinib

    monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • azilsartan medoxomil
  • Ultravist (iopromide)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    iopromide + azilsartan medoxomil

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • balsalazide
  • Ultravist (iopromide)
    +
    balsalazide
    1 interaction

    Monitor/Modify Tx

    iopromide + balsalazide

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • baricitinib
  • Ultravist (iopromide)
    +
    baricitinib
    1 interaction

    Monitor/Modify Tx

    iopromide + baricitinib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • bazedoxifene
  • Ultravist (iopromide)
    +
    bazedoxifene
    1 interaction

    Monitor/Modify Tx

    iopromide + bazedoxifene

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • benazepril
  • Ultravist (iopromide)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    iopromide + benazepril

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • bevacizumab
  • Ultravist (iopromide)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    iopromide + bevacizumab

    monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • binimetinib
  • Ultravist (iopromide)
    +
    binimetinib
    1 interaction

    Monitor/Modify Tx

    iopromide + binimetinib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • bleomycin
  • Ultravist (iopromide)
    +
    bleomycin
    1 interaction

    Monitor/Modify Tx

    iopromide + bleomycin

    monitor renal function; decr. bleomycin dose based on CrCl: combo may incr. bleomycin levels, risk of pulmonary toxicities (including life-threatening), other adverse effects (renal excretion decreased)

  • botulism immune globulin
  • Ultravist (iopromide)
    +
    botulism immune globulin
    1 interaction

    Monitor/Modify Tx

    iopromide + botulism immune globulin

    monitor renal function, thrombosis signs/symptoms; use lowest botulism immune globulin concentration and infusion rate possible: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • brolucizumab
  • Ultravist (iopromide)
    +
    brolucizumab
    1 interaction

    Monitor/Modify Tx

    iopromide + brolucizumab

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • C1 esterase inhibitor
  • Ultravist (iopromide)
    +
    C1 esterase inhibitor
    1 interaction

    Monitor/Modify Tx

    iopromide + C1 esterase inhibitor

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • cabozantinib
  • Ultravist (iopromide)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    iopromide + cabozantinib

    monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • calaspargase
  • Ultravist (iopromide)
    +
    calaspargase
    1 interaction

    Monitor/Modify Tx

    iopromide + calaspargase

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • candesartan cilexetil
  • Ultravist (iopromide)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    iopromide + candesartan cilexetil

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • capecitabine
  • Ultravist (iopromide)
    +
    capecitabine
    1 interaction

    Monitor/Modify Tx

    iopromide + capecitabine

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • captopril
  • Ultravist (iopromide)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    iopromide + captopril

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • carboplatin
  • Ultravist (iopromide)
    +
    carboplatin
    1 interaction

    Monitor/Modify Tx

    iopromide + carboplatin

    monitor CBC, renal function, ototoxicity: combo may incr. carboplatin levels, risk of serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • carfilzomib
  • Ultravist (iopromide)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    iopromide + carfilzomib

    monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • celecoxib
  • Ultravist (iopromide)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    iopromide + celecoxib

    monitor renal function, thrombosis signs/symptoms; use lowest effective celecoxib dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • chorionic gonadotropin
  • Ultravist (iopromide)
    +
    chorionic gonadotropin
    1 interaction

    Monitor/Modify Tx

    iopromide + chorionic gonadotropin

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • cisplatin
  • Ultravist (iopromide)
    +
    cisplatin
    1 interaction

    Monitor/Modify Tx

    iopromide + cisplatin

    monitor CBC, renal function, ototoxicity: combo may incr. cisplatin levels, risk of serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • clindamycin
  • Ultravist (iopromide)
    +
    clindamycin
    1 interaction

    Monitor/Modify Tx

    iopromide + clindamycin

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • clozapine
  • Ultravist (iopromide)
    +
    clozapine
    1 interaction

    Monitor/Modify Tx

    iopromide + clozapine

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • coagulation factor IX
  • Ultravist (iopromide)
    +
    coagulation factor IX
    1 interaction

    Monitor/Modify Tx

    iopromide + coagulation factor IX

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • coagulation factor VIIa
  • Ultravist (iopromide)
    +
    coagulation factor VIIa
    1 interaction

    Monitor/Modify Tx

    iopromide + coagulation factor VIIa

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • coagulation factor XIII A-subunit
  • Ultravist (iopromide)
    +
    coagulation factor XIII A-subunit
    1 interaction

    Monitor/Modify Tx

    iopromide + coagulation factor XIII A-subunit

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • colistimethate
  • Ultravist (iopromide)
    +
    colistimethate
    1 interaction

    Monitor/Modify Tx

    iopromide + colistimethate

    monitor renal function: combo may incr. colistimethate levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • concizumab
  • Ultravist (iopromide)
    +
    concizumab
    1 interaction

    Monitor/Modify Tx

    iopromide + concizumab

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • copper histidinate
  • Ultravist (iopromide)
    +
    copper histidinate
    1 interaction

    Monitor/Modify Tx

    iopromide + copper histidinate

    monitor renal function, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • creatine
  • Ultravist (iopromide)
    +
    creatine
    1 interaction

    Monitor/Modify Tx

    iopromide + creatine

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • cyclophosphamide
  • Ultravist (iopromide)
    +
    cyclophosphamide
    1 interaction

    Monitor/Modify Tx

    iopromide + cyclophosphamide

    monitor CBC, renal, cardiac function: combo may incr. cyclophosphamide levels, risk of serious infection, myelosuppression, nephrotoxicity, cardiotoxicity, other adverse effects (additive effects)

  • cyclosporine
  • Ultravist (iopromide)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    iopromide + cyclosporine

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • cytomegalovirus immune globulin
  • Ultravist (iopromide)
    +
    cytomegalovirus immune globulin
    1 interaction

    Monitor/Modify Tx

    iopromide + cytomegalovirus immune globulin

    monitor renal function, thrombosis signs/symptoms; use lowest cytomegalovirus immune globulin concentration and infusion rate possible: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • danazol
  • Ultravist (iopromide)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    iopromide + danazol

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • darbepoetin alfa
  • Ultravist (iopromide)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    iopromide + darbepoetin alfa

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • deferasirox
  • Ultravist (iopromide)
    +
    deferasirox
    1 interaction

    Monitor/Modify Tx

    iopromide + deferasirox

    monitor CBC, renal function, ototoxicity: combo may incr. deferasirox levels, risk of myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • deferoxamine
  • Ultravist (iopromide)
    +
    deferoxamine
    1 interaction

    Monitor/Modify Tx

    iopromide + deferoxamine

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • deflazacort
  • Ultravist (iopromide)
    +
    deflazacort
    1 interaction

    Monitor/Modify Tx

    iopromide + deflazacort

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • desogestrel (contraceptive)
  • Ultravist (iopromide)
    +
    desogestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopromide + desogestrel (contraceptive)

    monitor thrombosis signs/symptoms, especially with concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • deuruxolitinib
  • Ultravist (iopromide)
    +
    deuruxolitinib
    1 interaction

    Monitor/Modify Tx

    iopromide + deuruxolitinib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • dexamethasone
  • Ultravist (iopromide)
    +
    dexamethasone
    1 interaction

    Monitor/Modify Tx

    iopromide + dexamethasone

    monitor thrombosis signs/symptoms, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • diclofenac
  • Ultravist (iopromide)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    iopromide + diclofenac

    monitor renal function, thrombosis signs/symptoms; use lowest effective diclofenac dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • diclofenac topical
  • Ultravist (iopromide)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    iopromide + diclofenac topical

    monitor renal function, thrombosis signs/symptoms; use lowest effective diclofenac dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • dienogest (contraceptive)
  • Ultravist (iopromide)
    +
    dienogest (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopromide + dienogest (contraceptive)

    monitor thrombosis signs/symptoms, especially with concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • diflunisal
  • Ultravist (iopromide)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    iopromide + diflunisal

    monitor renal function, thrombosis signs/symptoms; use lowest effective diflunisal dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • drospirenone (contraceptive)
  • Ultravist (iopromide)
    +
    drospirenone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopromide + drospirenone (contraceptive)

    monitor thrombosis signs/symptoms, especially with concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • drospirenone (hormone replacement)
  • Ultravist (iopromide)
    +
    drospirenone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopromide + drospirenone (hormone replacement)

    monitor thrombosis signs/symptoms, especially with concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • eltrombopag
  • Ultravist (iopromide)
    +
    eltrombopag
    1 interaction

    Monitor/Modify Tx

    iopromide + eltrombopag

    monitor platelets, thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • enalapril
  • Ultravist (iopromide)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    iopromide + enalapril

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • enalaprilat
  • Ultravist (iopromide)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    iopromide + enalaprilat

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • epirubicin
  • Ultravist (iopromide)
    +
    epirubicin
    1 interaction

    Monitor/Modify Tx

    iopromide + epirubicin

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • epoetin alfa
  • Ultravist (iopromide)
    +
    epoetin alfa
    1 interaction

    Monitor/Modify Tx

    iopromide + epoetin alfa

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • estetrol (contraceptive)
  • Ultravist (iopromide)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopromide + estetrol (contraceptive)

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • estradiol (contraceptive)
  • Ultravist (iopromide)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopromide + estradiol (contraceptive)

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • estradiol (hormone replacement)
  • Ultravist (iopromide)
    +
    estradiol (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopromide + estradiol (hormone replacement)

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • estrogens, conjugated (hormone replacement)
  • Ultravist (iopromide)
    +
    estrogens, conjugated (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopromide + estrogens, conjugated (hormone replacement)

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • estrogens, esterified (hormone replacement)
  • Ultravist (iopromide)
    +
    estrogens, esterified (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopromide + estrogens, esterified (hormone replacement)

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • ethinyl estradiol (contraceptive)
  • Ultravist (iopromide)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopromide + ethinyl estradiol (contraceptive)

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • ethinyl estradiol (hormone replacement)
  • Ultravist (iopromide)
    +
    ethinyl estradiol (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopromide + ethinyl estradiol (hormone replacement)

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • ethynodiol (contraceptive)
  • Ultravist (iopromide)
    +
    ethynodiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopromide + ethynodiol (contraceptive)

    monitor thrombosis signs/symptoms, especially with concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • etodolac
  • Ultravist (iopromide)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    iopromide + etodolac

    monitor renal function, thrombosis signs/symptoms; use lowest effective etodolac dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • etonogestrel (contraceptive)
  • Ultravist (iopromide)
    +
    etonogestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopromide + etonogestrel (contraceptive)

    monitor thrombosis signs/symptoms, especially with concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • everolimus
  • Ultravist (iopromide)
    +
    everolimus
    1 interaction

    Monitor/Modify Tx

    iopromide + everolimus

    monitor renal function, thrombosis signs/symptoms, especially if immunosuppressant use: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • factor XIII concentrate
  • Ultravist (iopromide)
    +
    factor XIII concentrate
    1 interaction

    Monitor/Modify Tx

    iopromide + factor XIII concentrate

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • faricimab
  • Ultravist (iopromide)
    +
    faricimab
    1 interaction

    Monitor/Modify Tx

    iopromide + faricimab

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • fedratinib
  • Ultravist (iopromide)
    +
    fedratinib
    1 interaction

    Monitor/Modify Tx

    iopromide + fedratinib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • fenofibrate
  • Ultravist (iopromide)
    +
    fenofibrate
    1 interaction

    Monitor/Modify Tx

    iopromide + fenofibrate

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • fenofibric acid
  • Ultravist (iopromide)
    +
    fenofibric acid
    1 interaction

    Monitor/Modify Tx

    iopromide + fenofibric acid

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • fenoprofen
  • Ultravist (iopromide)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    iopromide + fenoprofen

    monitor renal function, thrombosis signs/symptoms; use lowest effective fenoprofen dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • fibrinogen (human)
  • Ultravist (iopromide)
    +
    fibrinogen (human)
    1 interaction

    Monitor/Modify Tx

    iopromide + fibrinogen (human)

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • fitusiran
  • Ultravist (iopromide)
    +
    fitusiran
    1 interaction

    Monitor/Modify Tx

    iopromide + fitusiran

    monitor antithrombin activity level, thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • flucytosine
  • Ultravist (iopromide)
    +
    flucytosine
    1 interaction

    Monitor/Modify Tx

    iopromide + flucytosine

    monitor CBC, renal function, flucytosine levels: combo may incr. flucytosine levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • flurbiprofen
  • Ultravist (iopromide)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    iopromide + flurbiprofen

    monitor renal function, thrombosis signs/symptoms; use lowest effective flurbiprofen dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • follitropin
  • Ultravist (iopromide)
    +
    follitropin
    1 interaction

    Monitor/Modify Tx

    iopromide + follitropin

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • fosinopril
  • Ultravist (iopromide)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    iopromide + fosinopril

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • fruquintinib
  • Ultravist (iopromide)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    iopromide + fruquintinib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • hepatitis B immune globulin
  • Ultravist (iopromide)
    +
    hepatitis B immune globulin
    1 interaction

    Monitor/Modify Tx

    iopromide + hepatitis B immune globulin

    monitor thrombosis signs/symptoms; use lowest hepatitis B immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • hydroxocobalamin IV
  • Ultravist (iopromide)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    iopromide + hydroxocobalamin IV

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • ibuprofen
  • Ultravist (iopromide)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    iopromide + ibuprofen

    monitor renal function, thrombosis signs/symptoms; use lowest effective ibuprofen dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • ibuprofen lysine
  • Ultravist (iopromide)
    +
    ibuprofen lysine
    1 interaction

    Monitor/Modify Tx

    iopromide + ibuprofen lysine

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • ifosfamide
  • Ultravist (iopromide)
    +
    ifosfamide
    1 interaction

    Monitor/Modify Tx

    iopromide + ifosfamide

    monitor CBC, renal, cardiac function: combo may incr. ifosfamide levels, risk of myelosuppression, serious infection, encephalopathy, nephrotoxicity, cardiotoxicity, other adverse effects (additive effects)

  • immune globulin
  • Ultravist (iopromide)
    +
    immune globulin
    1 interaction

    Monitor/Modify Tx

    iopromide + immune globulin

    monitor renal function, thrombosis signs/symptoms; use lowest immune globulin dose, concentration and infusion rate possible: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • indomethacin
  • Ultravist (iopromide)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    iopromide + indomethacin

    monitor renal function, thrombosis signs/symptoms; use lowest effective indomethacin dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • irbesartan
  • Ultravist (iopromide)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    iopromide + irbesartan

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • ketoprofen
  • Ultravist (iopromide)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    iopromide + ketoprofen

    monitor renal function, thrombosis signs/symptoms; use lowest effective ketoprofen dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • ketorolac
  • Ultravist (iopromide)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    iopromide + ketorolac

    monitor renal function, thrombosis signs/symptoms; use lowest effective ketorolac dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • lazertinib
  • Ultravist (iopromide)
    +
    lazertinib
    1 interaction

    Monitor/Modify Tx

    iopromide + lazertinib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • lenalidomide
  • Ultravist (iopromide)
    +
    lenalidomide
    1 interaction

    Monitor/Modify Tx

    iopromide + lenalidomide

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • lenvatinib
  • Ultravist (iopromide)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    iopromide + lenvatinib

    monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • levonorgestrel (contraceptive)
  • Ultravist (iopromide)
    +
    levonorgestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopromide + levonorgestrel (contraceptive)

    monitor thrombosis signs/symptoms, especially with concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • levonorgestrel (hormone replacement)
  • Ultravist (iopromide)
    +
    levonorgestrel (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopromide + levonorgestrel (hormone replacement)

    monitor thrombosis signs/symptoms, especially with concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • lifileucel
  • Ultravist (iopromide)
    +
    lifileucel
    1 interaction

    Monitor/Modify Tx

    iopromide + lifileucel

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • lisinopril
  • Ultravist (iopromide)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    iopromide + lisinopril

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • lithium
  • Ultravist (iopromide)
    +
    lithium
    1 interaction

    Monitor/Modify Tx

    iopromide + lithium

    monitor lithium levels, renal function: combo may incr. lithium levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • lomustine
  • Ultravist (iopromide)
    +
    lomustine
    1 interaction

    Monitor/Modify Tx

    iopromide + lomustine

    monitor CBC, renal function: combo may incr. lomustine levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • losartan
  • Ultravist (iopromide)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    iopromide + losartan

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • luspatercept
  • Ultravist (iopromide)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    iopromide + luspatercept

    if beta thalassemia use, monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • lusutrombopag
  • Ultravist (iopromide)
    +
    lusutrombopag
    1 interaction

    Monitor/Modify Tx

    iopromide + lusutrombopag

    monitor platelets, thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • lutetium Lu 177 vipivotide tetraxetan
  • Ultravist (iopromide)
    +
    lutetium Lu 177 vipivotide tetraxetan
    1 interaction

    Monitor/Modify Tx

    iopromide + lutetium Lu 177 vipivotide tetraxetan

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • magnesium salicylate
  • Ultravist (iopromide)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    iopromide + magnesium salicylate

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • meclofenamate
  • Ultravist (iopromide)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    iopromide + meclofenamate

    monitor renal function, thrombosis signs/symptoms; use lowest effective meclofenamate dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • medroxyprogesterone (contraceptive)
  • Ultravist (iopromide)
    +
    medroxyprogesterone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopromide + medroxyprogesterone (contraceptive)

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • medroxyprogesterone (hormone replacement)
  • Ultravist (iopromide)
    +
    medroxyprogesterone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopromide + medroxyprogesterone (hormone replacement)

    monitor thrombosis signs/symptoms, especially with concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • mefenamic acid
  • Ultravist (iopromide)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    iopromide + mefenamic acid

    monitor renal function, thrombosis signs/symptoms; use lowest effective mefenamic acid dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • megestrol
  • Ultravist (iopromide)
    +
    megestrol
    1 interaction

    Monitor/Modify Tx

    iopromide + megestrol

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • meloxicam
  • Ultravist (iopromide)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    iopromide + meloxicam

    monitor renal function, thrombosis signs/symptoms; use lowest effective meloxicam dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • menotropins
  • Ultravist (iopromide)
    +
    menotropins
    1 interaction

    Monitor/Modify Tx

    iopromide + menotropins

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • mesalamine
  • Ultravist (iopromide)
    +
    mesalamine
    1 interaction

    Monitor/Modify Tx

    iopromide + mesalamine

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • mesalamine rectal
  • Ultravist (iopromide)
    +
    mesalamine rectal
    1 interaction

    Monitor/Modify Tx

    iopromide + mesalamine rectal

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • metformin
  • Ultravist (iopromide)
    +
    metformin
    1 interaction

    Monitor/Modify Tx

    iopromide + metformin

    hold metformin if GFR 30-60 mL/min, hepatic impairment, alcoholism, heart failure or if receiving intra-arterial iodinated contrast; may restart metformin if stable renal function 48h after iopromide use: combo may increase risk of lactic acidosis (possible additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • Ultravist (iopromide)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    iopromide + methoxy polyethylene glycol-epoetin beta

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • methyltestosterone
  • Ultravist (iopromide)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    iopromide + methyltestosterone

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • mitomycin
  • Ultravist (iopromide)
    +
    mitomycin
    1 interaction

    Monitor/Modify Tx

    iopromide + mitomycin

    monitor renal function; risk may be lower with intravesical mitomycin administration: combo may incr. risk of nephrotoxicity (additive effects)

  • moexipril
  • Ultravist (iopromide)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    iopromide + moexipril

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • momelotinib
  • Ultravist (iopromide)
    +
    momelotinib
    1 interaction

    Monitor/Modify Tx

    iopromide + momelotinib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • nabumetone
  • Ultravist (iopromide)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    iopromide + nabumetone

    monitor renal function, thrombosis signs/symptoms; use lowest effective nabumetone dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • naproxen
  • Ultravist (iopromide)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    iopromide + naproxen

    monitor renal function, thrombosis signs/symptoms; use lowest effective naproxen dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • necitumumab
  • Ultravist (iopromide)
    +
    necitumumab
    1 interaction

    Monitor/Modify Tx

    iopromide + necitumumab

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • neomycin
  • Ultravist (iopromide)
    +
    neomycin
    1 interaction

    Monitor/Modify Tx

    iopromide + neomycin

    if compromised gut wall allows for neomycin absorption, monitor renal function, ototoxicity: combo may incr. neomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • nintedanib
  • Ultravist (iopromide)
    +
    nintedanib
    1 interaction

    Monitor/Modify Tx

    iopromide + nintedanib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • norelgestromin (contraceptive)
  • Ultravist (iopromide)
    +
    norelgestromin (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopromide + norelgestromin (contraceptive)

    monitor thrombosis signs/symptoms, especially with concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • norethindrone (contraceptive)
  • Ultravist (iopromide)
    +
    norethindrone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopromide + norethindrone (contraceptive)

    monitor thrombosis signs/symptoms, especially with concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • norethindrone (hormone replacement)
  • Ultravist (iopromide)
    +
    norethindrone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopromide + norethindrone (hormone replacement)

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • norgestimate (contraceptive)
  • Ultravist (iopromide)
    +
    norgestimate (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopromide + norgestimate (contraceptive)

    monitor thrombosis signs/symptoms, especially with concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • norgestrel (contraceptive)
  • Ultravist (iopromide)
    +
    norgestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopromide + norgestrel (contraceptive)

    monitor thrombosis signs/symptoms, especially with concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • nusinersen
  • Ultravist (iopromide)
    +
    nusinersen
    1 interaction

    Monitor/Modify Tx

    iopromide + nusinersen

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • obinutuzumab
  • Ultravist (iopromide)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    iopromide + obinutuzumab

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • olaparib
  • Ultravist (iopromide)
    +
    olaparib
    1 interaction

    Monitor/Modify Tx

    iopromide + olaparib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • olmesartan medoxomil
  • Ultravist (iopromide)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    iopromide + olmesartan medoxomil

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • olsalazine
  • Ultravist (iopromide)
    +
    olsalazine
    1 interaction

    Monitor/Modify Tx

    iopromide + olsalazine

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • ospemifene
  • Ultravist (iopromide)
    +
    ospemifene
    1 interaction

    Monitor/Modify Tx

    iopromide + ospemifene

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • oxaprozin
  • Ultravist (iopromide)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    iopromide + oxaprozin

    monitor renal function, thrombosis signs/symptoms; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • pacritinib
  • Ultravist (iopromide)
    +
    pacritinib
    1 interaction

    Monitor/Modify Tx

    iopromide + pacritinib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • pamidronate
  • Ultravist (iopromide)
    +
    pamidronate
    1 interaction

    Monitor/Modify Tx

    iopromide + pamidronate

    monitor renal function: combo may incr. pamidronate levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • paromomycin
  • Ultravist (iopromide)
    +
    paromomycin
    1 interaction

    Monitor/Modify Tx

    iopromide + paromomycin

    if compromised gut wall allows for paromomycin absorption, monitor renal function, ototoxicity: combo may incr. paromomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • pazopanib
  • Ultravist (iopromide)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    iopromide + pazopanib

    monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • pegaspargase
  • Ultravist (iopromide)
    +
    pegaspargase
    1 interaction

    Monitor/Modify Tx

    iopromide + pegaspargase

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • pemetrexed
  • Ultravist (iopromide)
    +
    pemetrexed
    1 interaction

    Monitor/Modify Tx

    iopromide + pemetrexed

    monitor CBC, renal function: combo may incr. pemetrexed levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • penicillamine
  • Ultravist (iopromide)
    +
    penicillamine
    1 interaction

    Monitor/Modify Tx

    iopromide + penicillamine

    monitor CBC, renal function: combo may incr. penicillamine levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • pentostatin
  • Ultravist (iopromide)
    +
    pentostatin
    1 interaction

    Monitor/Modify Tx

    iopromide + pentostatin

    monitor CBC, renal function: combo may incr. pentostatin levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • perindopril
  • Ultravist (iopromide)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    iopromide + perindopril

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • piroxicam
  • Ultravist (iopromide)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    iopromide + piroxicam

    monitor renal function, thrombosis signs/symptoms; use lowest effective piroxicam dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • plazomicin
  • Ultravist (iopromide)
    +
    plazomicin
    1 interaction

    Monitor/Modify Tx

    iopromide + plazomicin

    monitor plazomicin levels, renal function, ototoxicity: combo may incr. plazomicin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • pomalidomide
  • Ultravist (iopromide)
    +
    pomalidomide
    1 interaction

    Monitor/Modify Tx

    iopromide + pomalidomide

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • ponatinib
  • Ultravist (iopromide)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    iopromide + ponatinib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • porfimer
  • Ultravist (iopromide)
    +
    porfimer
    1 interaction

    Monitor/Modify Tx

    iopromide + porfimer

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • progesterone (hormone replacement)
  • Ultravist (iopromide)
    +
    progesterone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopromide + progesterone (hormone replacement)

    monitor thrombosis signs/symptoms, especially with concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • progesterone vaginal (hormone replacement)
  • Ultravist (iopromide)
    +
    progesterone vaginal (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopromide + progesterone vaginal (hormone replacement)

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • prothrombin complex concentrate (human)
  • Ultravist (iopromide)
    +
    prothrombin complex concentrate (human)
    1 interaction

    Monitor/Modify Tx

    iopromide + prothrombin complex concentrate (human)

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • quinapril
  • Ultravist (iopromide)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    iopromide + quinapril

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • raloxifene
  • Ultravist (iopromide)
    +
    raloxifene
    1 interaction

    Monitor/Modify Tx

    iopromide + raloxifene

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • ramipril
  • Ultravist (iopromide)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    iopromide + ramipril

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • ramucirumab
  • Ultravist (iopromide)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    iopromide + ramucirumab

    monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • ranibizumab
  • Ultravist (iopromide)
    +
    ranibizumab
    1 interaction

    Monitor/Modify Tx

    iopromide + ranibizumab

    monitor thrombosis signs/symptoms; risk may be lower if ocular implant use: combo may incr. risk of thromboembolism (additive effects)

  • Rho(D) immune globulin
  • Ultravist (iopromide)
    +
    Rho(D) immune globulin
    1 interaction

    Monitor/Modify Tx

    iopromide + Rho(D) immune globulin

    monitor renal function, thrombosis signs/symptoms; use lowest Rho(D) immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • ritlecitinib
  • Ultravist (iopromide)
    +
    ritlecitinib
    1 interaction

    Monitor/Modify Tx

    iopromide + ritlecitinib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • rituximab
  • Ultravist (iopromide)
    +
    rituximab
    1 interaction

    Monitor/Modify Tx

    iopromide + rituximab

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • romiplostim
  • Ultravist (iopromide)
    +
    romiplostim
    1 interaction

    Monitor/Modify Tx

    iopromide + romiplostim

    monitor platelets, thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • ropeginterferon alfa-2b
  • Ultravist (iopromide)
    +
    ropeginterferon alfa-2b
    1 interaction

    Monitor/Modify Tx

    iopromide + ropeginterferon alfa-2b

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • ruxolitinib
  • Ultravist (iopromide)
    +
    ruxolitinib
    1 interaction

    Monitor/Modify Tx

    iopromide + ruxolitinib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • ruxolitinib topical
  • Ultravist (iopromide)
    +
    ruxolitinib topical
    1 interaction

    Monitor/Modify Tx

    iopromide + ruxolitinib topical

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • salsalate
  • Ultravist (iopromide)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    iopromide + salsalate

    monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • segesterone (contraceptive)
  • Ultravist (iopromide)
    +
    segesterone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopromide + segesterone (contraceptive)

    monitor thrombosis signs/symptoms, especially with concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • sipuleucel-T
  • Ultravist (iopromide)
    +
    sipuleucel-T
    1 interaction

    Monitor/Modify Tx

    iopromide + sipuleucel-T

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • sirolimus
  • Ultravist (iopromide)
    +
    sirolimus
    1 interaction

    Monitor/Modify Tx

    iopromide + sirolimus

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • sitagliptin
  • Ultravist (iopromide)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    iopromide + sitagliptin

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • sodium tetradecyl sulfate
  • Ultravist (iopromide)
    +
    sodium tetradecyl sulfate
    1 interaction

    Monitor/Modify Tx

    iopromide + sodium tetradecyl sulfate

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • sotatercept
  • Ultravist (iopromide)
    +
    sotatercept
    1 interaction

    Monitor/Modify Tx

    iopromide + sotatercept

    monitor Hgb, thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • sparsentan
  • Ultravist (iopromide)
    +
    sparsentan
    1 interaction

    Monitor/Modify Tx

    iopromide + sparsentan

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • sulindac
  • Ultravist (iopromide)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    iopromide + sulindac

    monitor renal function, thrombosis signs/symptoms; use lowest effective sulindac dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • sunitinib
  • Ultravist (iopromide)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    iopromide + sunitinib

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • tacrolimus
  • Ultravist (iopromide)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    iopromide + tacrolimus

    monitor tacrolimus levels, renal function: combo may incr. tacrolimus levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • tamoxifen
  • Ultravist (iopromide)
    +
    tamoxifen
    1 interaction

    Monitor/Modify Tx

    iopromide + tamoxifen

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • telavancin
  • Ultravist (iopromide)
    +
    telavancin
    1 interaction

    Monitor/Modify Tx

    iopromide + telavancin

    monitor ECG, renal function: combo may incr. telavancin levels, risk of QT prolongation, cardiac arrhythmias, nephrotoxicity, other adverse effects (additive effects)

  • telmisartan
  • Ultravist (iopromide)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    iopromide + telmisartan

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • temsirolimus
  • Ultravist (iopromide)
    +
    temsirolimus
    1 interaction

    Monitor/Modify Tx

    iopromide + temsirolimus

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • tenofovir alafenamide
  • Ultravist (iopromide)
    +
    tenofovir alafenamide
    1 interaction

    Monitor/Modify Tx

    iopromide + tenofovir alafenamide

    monitor renal function: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • testosterone
  • Ultravist (iopromide)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    iopromide + testosterone

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • thalidomide
  • Ultravist (iopromide)
    +
    thalidomide
    1 interaction

    Monitor/Modify Tx

    iopromide + thalidomide

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • tiopronin
  • Ultravist (iopromide)
    +
    tiopronin
    1 interaction

    Monitor/Modify Tx

    iopromide + tiopronin

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • tivozanib
  • Ultravist (iopromide)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    iopromide + tivozanib

    monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • tofacitinib
  • Ultravist (iopromide)
    +
    tofacitinib
    1 interaction

    Monitor/Modify Tx

    iopromide + tofacitinib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • tolmetin
  • Ultravist (iopromide)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    iopromide + tolmetin

    monitor renal function, thrombosis signs/symptoms; use lowest effective tolmetin dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • toremifene
  • Ultravist (iopromide)
    +
    toremifene
    1 interaction

    Monitor/Modify Tx

    iopromide + toremifene

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • trametinib
  • Ultravist (iopromide)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    iopromide + trametinib

    monitor thrombosis signs/symptoms, especially in combo with dabrafenib: combo may incr. risk of thromboembolism (additive effects)

  • trandolapril
  • Ultravist (iopromide)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    iopromide + trandolapril

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • tretinoin
  • Ultravist (iopromide)
    +
    tretinoin
    1 interaction

    Monitor/Modify Tx

    iopromide + tretinoin

    monitor thrombosis signs/symptoms, especially during 1st month of tretinoin use: combo may incr. risk of thromboembolism (additive effects)

  • upadacitinib
  • Ultravist (iopromide)
    +
    upadacitinib
    1 interaction

    Monitor/Modify Tx

    iopromide + upadacitinib

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • vadadustat
  • Ultravist (iopromide)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    iopromide + vadadustat

    monitor Hgb, thrombosis signs/symptoms; use lowest effective vadadustat dose: combo may incr. risk of thromboembolism (additive effects)

  • valacyclovir
  • Ultravist (iopromide)
    +
    valacyclovir
    1 interaction

    Monitor/Modify Tx

    iopromide + valacyclovir

    monitor renal function: combo may incr. acyclovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • valoctocogene roxaparvovec
  • Ultravist (iopromide)
    +
    valoctocogene roxaparvovec
    1 interaction

    Monitor/Modify Tx

    iopromide + valoctocogene roxaparvovec

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • valsartan
  • Ultravist (iopromide)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    iopromide + valsartan

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • vamorolone
  • Ultravist (iopromide)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    iopromide + vamorolone

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • vancomycin
  • Ultravist (iopromide)
    +
    vancomycin
    1 interaction

    Monitor/Modify Tx

    iopromide + vancomycin

    VANCOMYCIN IV: monitor renal function, vancomycin levels, ototoxicity; VANCOMYCIN PO: consider monitoring renal function, vancomycin levels, ototoxicity in pts with severe renal impairment, severe intestinal inflammation, or prolonged course >2 g/day: combo may incr. vancomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects; increased oral vancomycin absorption if inflamed or compromised gut mucosa)

  • varicella zoster immune globulin
  • Ultravist (iopromide)
    +
    varicella zoster immune globulin
    1 interaction

    Monitor/Modify Tx

    iopromide + varicella zoster immune globulin

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • voclosporin
  • Ultravist (iopromide)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    iopromide + voclosporin

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • von Willebrand factor
  • Ultravist (iopromide)
    +
    von Willebrand factor
    1 interaction

    Monitor/Modify Tx

    iopromide + von Willebrand factor

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • vorinostat
  • Ultravist (iopromide)
    +
    vorinostat
    1 interaction

    Monitor/Modify Tx

    iopromide + vorinostat

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • willow bark
  • Ultravist (iopromide)
    +
    willow bark
    1 interaction

    Monitor/Modify Tx

    iopromide + willow bark

    monitor renal function, especially with high-dose willow bark: combo may incr. risk of nephrotoxicity (additive effects, willow bark may contain salicylates)

  • ziv-aflibercept
  • Ultravist (iopromide)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    iopromide + ziv-aflibercept

    monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • zoledronic acid
  • Ultravist (iopromide)
    +
    zoledronic acid
    1 interaction

    Monitor/Modify Tx

    iopromide + zoledronic acid

    monitor renal function: combo may incr. zoledronic acid levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • zonisamide
  • Ultravist (iopromide)
    +
    zonisamide
    1 interaction

    Monitor/Modify Tx

    iopromide + zonisamide

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • zopapogene imadenovec
  • Ultravist (iopromide)
    +
    zopapogene imadenovec
    1 interaction

    Monitor/Modify Tx

    iopromide + zopapogene imadenovec

    monitor thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@f4f0c54
  • hypersensitivity reaction
  • anaphylaxis
  • cutaneous reaction, severe
  • acute kidney injury
  • hypotension
  • shock
  • cardiac arrest
  • arrhythmia
  • thromboembolism (angiography use)
  • extravasation symptoms
  • thyroid dysfunction (peds patients)
  • seizures
  • pulmonary edema

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@1c189985
  • headache
  • injection site reaction
  • nausea
  • vasodilation

Safety/Monitoring .

Monitoring Parameters
no routine tests recommended

Pregnancy/Lactation .

Pregnancy

Clinical Summary

may use during pregnancy; no human data available; no known risk of fetal harm based on animal data at 0.35-0.7x MRHD

Lactation

Clinical Summary

may use while breastfeeding; no human data available, though risk of infant harm not expected based on minimal drug excretion into milk; no human data available to assess effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@28af71a5

Metabolism: for iopromide: none; CYP450: none

Excretion: for iopromide: urine 97% (100% unchanged); Half-life: 2h (main phase), 6.2h (terminal phase)

Subclass: Contrast Agents

Mechanism of Action
for iopromide: attenuates X-ray beams and opacifies vessels and anatomical structures, enhancing visualization of normal and pathological tissue (nonionic iodine-based contrast medium)

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Bayer HealthCare Pharmaceuticals

com.epocrates.rxweb.beans.DrugOtherInfoBean@468edd28

DEA/FDA: Rx

Retail Price

This information is currently not available for this drug.

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information